JP2025501762A5 - - Google Patents
Info
- Publication number
- JP2025501762A5 JP2025501762A5 JP2024538278A JP2024538278A JP2025501762A5 JP 2025501762 A5 JP2025501762 A5 JP 2025501762A5 JP 2024538278 A JP2024538278 A JP 2024538278A JP 2024538278 A JP2024538278 A JP 2024538278A JP 2025501762 A5 JP2025501762 A5 JP 2025501762A5
- Authority
- JP
- Japan
- Prior art keywords
- partially unsaturated
- independently selected
- methyl
- member saturated
- nitrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163292903P | 2021-12-22 | 2021-12-22 | |
| US63/292,903 | 2021-12-22 | ||
| US202263327228P | 2022-04-04 | 2022-04-04 | |
| US63/327,228 | 2022-04-04 | ||
| US202263403459P | 2022-09-02 | 2022-09-02 | |
| US63/403,459 | 2022-09-02 | ||
| PCT/US2022/053591 WO2023122140A1 (en) | 2021-12-22 | 2022-12-21 | Parp1 inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501762A JP2025501762A (ja) | 2025-01-23 |
| JP2025501762A5 true JP2025501762A5 (enExample) | 2026-01-06 |
Family
ID=85156997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024538278A Pending JP2025501762A (ja) | 2021-12-22 | 2022-12-21 | Ｐａｒｐ１阻害剤 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20250163022A1 (enExample) |
| EP (1) | EP4452963A1 (enExample) |
| JP (1) | JP2025501762A (enExample) |
| KR (1) | KR20240136978A (enExample) |
| AU (1) | AU2022420969A1 (enExample) |
| CA (1) | CA3241875A1 (enExample) |
| CL (1) | CL2024001874A1 (enExample) |
| CO (1) | CO2024009571A2 (enExample) |
| CR (1) | CR20240296A (enExample) |
| IL (1) | IL313727A (enExample) |
| MX (1) | MX2024007673A (enExample) |
| PE (1) | PE20242004A1 (enExample) |
| TW (1) | TW202332438A (enExample) |
| WO (1) | WO2023122140A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL305262A (en) | 2021-03-10 | 2023-10-01 | Jnana Therapeutics Inc | Small molecule inhibitors of mammalian SLC6A19 function |
| AU2023229992A1 (en) * | 2022-03-11 | 2024-10-10 | Impact Therapeutics (Shanghai), Inc. | Substituted tricyclic compounds as parp inhibitors and the use thereof |
| US20250214980A1 (en) | 2022-03-14 | 2025-07-03 | Slap Pharmaceuticals Llc | Multicyclic compounds |
| AU2023299635A1 (en) * | 2022-06-27 | 2025-01-02 | Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd | Tricyclic compounds and uses thereof |
| CN115232129B (zh) * | 2022-08-18 | 2023-12-01 | 上海闻耐医药科技有限公司 | 一种parp1选择性抑制剂及其制备方法和用途 |
| CN120092010A (zh) * | 2022-11-02 | 2025-06-03 | 轩竹生物科技股份有限公司 | 多环类聚（adp核糖）聚合酶选择性抑制剂 |
| AU2023378452A1 (en) * | 2022-11-10 | 2025-06-19 | Haihe Biopharma Co., Ltd. | Fused tricyclic parp1 inhibitor, preparation method therefor, and use thereof |
| TW202506680A (zh) * | 2023-04-28 | 2025-02-16 | 美商思諾維新醫藥公司 | 作為ｐａｒｐ１抑制劑之雜環化合物 |
| CN119462669A (zh) * | 2023-08-11 | 2025-02-18 | 上海海和药物研究开发股份有限公司 | 稠合三环类化合物、其药物组合物和用途 |
| WO2025067417A1 (zh) * | 2023-09-28 | 2025-04-03 | 成都赜灵生物医药科技有限公司 | 并内酰胺环类化合物及其用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8541417B2 (en) * | 2009-07-30 | 2013-09-24 | Takeda Pharmaceutical Company Limited | Poly (ADP-ribose) polymerase (PARP) inhibitors |
| JPWO2015060348A1 (ja) * | 2013-10-23 | 2017-03-09 | 大日本住友製薬株式会社 | 縮合ピラゾール誘導体 |
| PT3312177T (pt) * | 2015-06-09 | 2021-05-17 | Onconic Therapeutics Inc | Composto derivado tricíclico, método para preparar o mesmo e composição farmacêutica compreendendo o mesmo |
| TWI837403B (zh) * | 2019-07-19 | 2024-04-01 | 瑞典商阿斯特捷利康公司 | 化學化合物 |
-
2022
- 2022-12-21 WO PCT/US2022/053591 patent/WO2023122140A1/en not_active Ceased
- 2022-12-21 PE PE2024001409A patent/PE20242004A1/es unknown
- 2022-12-21 IL IL313727A patent/IL313727A/en unknown
- 2022-12-21 US US18/728,407 patent/US20250163022A1/en active Pending
- 2022-12-21 EP EP22851230.7A patent/EP4452963A1/en active Pending
- 2022-12-21 MX MX2024007673A patent/MX2024007673A/es unknown
- 2022-12-21 TW TW111149299A patent/TW202332438A/zh unknown
- 2022-12-21 KR KR1020247024155A patent/KR20240136978A/ko active Pending
- 2022-12-21 JP JP2024538278A patent/JP2025501762A/ja active Pending
- 2022-12-21 CA CA3241875A patent/CA3241875A1/en active Pending
- 2022-12-21 AU AU2022420969A patent/AU2022420969A1/en active Pending
- 2022-12-21 CR CR20240296A patent/CR20240296A/es unknown
-
2024
- 2024-06-19 CL CL2024001874A patent/CL2024001874A1/es unknown
- 2024-07-19 CO CONC2024/0009571A patent/CO2024009571A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12391663B2 (en) | Isoindolinone compounds | |
| JP7169412B2 (ja) | 抗癌活性及び抗増殖活性を呈する２－アミノピリミジン－６－オン及び類似体 | |
| JP7012152B2 (ja) | Ｆｓｈｄの治療のためにｄｕｘ４および下流遺伝子発現を低減するｐ３８キナーゼ阻害剤 | |
| RU2699546C2 (ru) | Комбинированная терапия для лечения рака | |
| KR102154946B1 (ko) | 아릴- 또는 헤테로아릴-치환된 벤젠 화합물 | |
| JP6387360B2 (ja) | 変異ｉｄｈの阻害薬としての３−ピリミジン−４−イル−オキサゾリジン−２−オン | |
| RU2769607C2 (ru) | N-ацил-N'-(пиридин-2-ил) карбамиды и их аналоги, проявляющие противораковую и антипролиферативную активность | |
| AU2022211789A1 (en) | Heteroaryl derivative, method for producing the same, and pharmaceutical composition comprising same as effective component | |
| JP6529492B2 (ja) | 癌の処置のためのｉｄｈ２突然変異体阻害剤としての２，４−または４，６−ジアミノピリミジン化合物 | |
| US9446064B2 (en) | Combination therapy for treating cancer | |
| US20160045531A1 (en) | Combination therapy for treating cancer | |
| JP2019514903A5 (enExample) | ||
| TWI831829B (zh) | 苯氧基-吡啶基-嘧啶化合物及使用方法 | |
| TWI601712B (zh) | 作為ｇｌｙｔ１抑制劑之經取代之氮雜環丁基化合物 | |
| TWI804545B (zh) | 化合物 | |
| AU2018200826A1 (en) | Aryl-or heteroaryl-substituted benzene compounds |